Clariant AG ( (CLZNF) ) has released its Q2 earnings. Here is a breakdown of the information Clariant AG presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Clariant AG is a Swiss-based specialty chemical company that focuses on sustainability and innovation, operating through three main business units: Care Chemicals, Catalysts, and Adsorbents & Additives. The company is known for its commitment to creating solutions that foster sustainability across various industries.
In its latest earnings report for the second quarter of 2025, Clariant AG reported sales of CHF 968 million, maintaining flat sales in local currencies despite significant currency headwinds. The company’s EBITDA margin before exceptional items improved by 200 basis points to 17.5%, driven by strong performance in Catalysts and Adsorbents & Additives. However, restructuring charges impacted the reported EBITDA margin.
Key financial highlights include a 1% increase in first-half 2025 sales in local currencies to CHF 1.981 billion, with a corresponding EBITDA margin before exceptional items rising to 18.1%. The company also reported operating cash flow of CHF 116 million and a free cash flow conversion rate of 37%. Strategic initiatives, such as the Investor Day savings program, are underway, contributing to cost savings and improved profitability.
Looking ahead, Clariant AG has adjusted its 2025 sales growth outlook to 1-3% in local currencies, reflecting ongoing market uncertainties. However, the company remains confident in achieving its full-year profitability target of a 17-18% EBITDA margin before exceptional items. Clariant continues to focus on delivering its medium-term targets by 2027, supported by ongoing strategic initiatives and a commitment to sustainability.